OLINVYK Drug Patent Profile
✉ Email this page to a colleague
When do Olinvyk patents expire, and what generic alternatives are available?
Olinvyk is a drug marketed by Trevena and is included in one NDA. There are four patents protecting this drug.
This drug has fifty-one patent family members in twenty-three countries.
The generic ingredient in OLINVYK is oliceridine. One supplier is listed for this compound. Additional details are available on the oliceridine profile page.
DrugPatentWatch® Generic Entry Outlook for Olinvyk
Olinvyk will be eligible for patent challenges on October 30, 2024. This date may extended up to six months if a pediatric exclusivity extension is applied to the drug's patents.
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be March 23, 2032. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
Summary for OLINVYK
International Patents: | 51 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Patent Applications: | 56 |
Drug Prices: | Drug price information for OLINVYK |
What excipients (inactive ingredients) are in OLINVYK? | OLINVYK excipients list |
DailyMed Link: | OLINVYK at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for OLINVYK
Generic Entry Date for OLINVYK*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
SOLUTION;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Anatomical Therapeutic Chemical (ATC) Classes for OLINVYK
US Patents and Regulatory Information for OLINVYK
OLINVYK is protected by four US patents and one FDA Regulatory Exclusivity.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of OLINVYK is ⤷ Try a Trial.
This potential generic entry date is based on patent ⤷ Try a Trial.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting OLINVYK
Opioid receptor ligands and methods of using and making same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: MANAGEMENT OF ACUTE PAIN BY INTRAVENOUS INJECTION
Opioid receptor ligands and methods of using and making same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: MANAGEMENT OF ACUTE PAIN BY INTRAVENOUS INJECTION
Opioid receptor ligands and methods of using and making same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: MANAGEMENT OF ACUTE PAIN BY INTRAVENOUS INJECTION
Opioid receptor ligands and methods of using and making same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: MANAGEMENT OF ACUTE PAIN BY INTRAVENOUS INJECTION
FDA Regulatory Exclusivity protecting OLINVYK
NEW CHEMICAL ENTITY
Exclusivity Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-001 | Oct 30, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-002 | Oct 30, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-001 | Oct 30, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-003 | Oct 30, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-002 | Oct 30, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-003 | Oct 30, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for OLINVYK
When does loss-of-exclusivity occur for OLINVYK?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Australia
Patent: 12230761
Estimated Expiration: ⤷ Try a Trial
Patent: 17200745
Estimated Expiration: ⤷ Try a Trial
Brazil
Patent: 2013024136
Estimated Expiration: ⤷ Try a Trial
Canada
Patent: 30742
Estimated Expiration: ⤷ Try a Trial
China
Patent: 3702561
Estimated Expiration: ⤷ Try a Trial
Croatia
Patent: 0171021
Estimated Expiration: ⤷ Try a Trial
Cyprus
Patent: 19057
Estimated Expiration: ⤷ Try a Trial
Denmark
Patent: 88403
Estimated Expiration: ⤷ Try a Trial
Patent: 90415
Estimated Expiration: ⤷ Try a Trial
Eurasian Patent Organization
Patent: 5456
Estimated Expiration: ⤷ Try a Trial
Patent: 1391332
Estimated Expiration: ⤷ Try a Trial
European Patent Office
Patent: 88403
Estimated Expiration: ⤷ Try a Trial
Patent: 90415
Estimated Expiration: ⤷ Try a Trial
Patent: 72076
Estimated Expiration: ⤷ Try a Trial
Hong Kong
Patent: 50984
Estimated Expiration: ⤷ Try a Trial
Hungary
Patent: 32948
Estimated Expiration: ⤷ Try a Trial
Patent: 54055
Estimated Expiration: ⤷ Try a Trial
Israel
Patent: 8506
Estimated Expiration: ⤷ Try a Trial
Patent: 3318
Estimated Expiration: ⤷ Try a Trial
Patent: 2165
Estimated Expiration: ⤷ Try a Trial
Patent: 4407
Estimated Expiration: ⤷ Try a Trial
Japan
Patent: 12169
Estimated Expiration: ⤷ Try a Trial
Patent: 43949
Estimated Expiration: ⤷ Try a Trial
Patent: 49341
Estimated Expiration: ⤷ Try a Trial
Patent: 23683
Estimated Expiration: ⤷ Try a Trial
Patent: 48750
Estimated Expiration: ⤷ Try a Trial
Patent: 14508811
Estimated Expiration: ⤷ Try a Trial
Patent: 16155843
Estimated Expiration: ⤷ Try a Trial
Patent: 18048193
Estimated Expiration: ⤷ Try a Trial
Patent: 20073570
Estimated Expiration: ⤷ Try a Trial
Patent: 21176885
Estimated Expiration: ⤷ Try a Trial
Patent: 23075282
Estimated Expiration: ⤷ Try a Trial
Lithuania
Patent: 88403
Estimated Expiration: ⤷ Try a Trial
Montenegro
Patent: 754
Estimated Expiration: ⤷ Try a Trial
New Zealand
Patent: 5993
Estimated Expiration: ⤷ Try a Trial
Patent: 3143
Estimated Expiration: ⤷ Try a Trial
Poland
Patent: 88403
Estimated Expiration: ⤷ Try a Trial
Patent: 90415
Estimated Expiration: ⤷ Try a Trial
Portugal
Patent: 88403
Estimated Expiration: ⤷ Try a Trial
Patent: 90415
Estimated Expiration: ⤷ Try a Trial
Serbia
Patent: 111
Estimated Expiration: ⤷ Try a Trial
Slovenia
Patent: 88403
Estimated Expiration: ⤷ Try a Trial
South Korea
Patent: 1991326
Estimated Expiration: ⤷ Try a Trial
Patent: 1991327
Estimated Expiration: ⤷ Try a Trial
Patent: 2129247
Estimated Expiration: ⤷ Try a Trial
Patent: 140047599
Estimated Expiration: ⤷ Try a Trial
Patent: 180100453
Estimated Expiration: ⤷ Try a Trial
Patent: 190072665
Estimated Expiration: ⤷ Try a Trial
Spain
Patent: 32009
Estimated Expiration: ⤷ Try a Trial
Patent: 57549
Estimated Expiration: ⤷ Try a Trial
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering OLINVYK around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hungary | E054055 | ⤷ Try a Trial | |
Montenegro | 02754 | LIGANDI OPIOIDNIH RECEPTORA I POSTUPCI NJIHOVE UPOTREBE I PRIPREME (OPIOID RECEPTOR LIGANDS AND METHODS OF USING AND MAKING SAME) | ⤷ Try a Trial |
Israel | 243318 | ליגנדים של קולטן אופיואיד ושיטות לשימוש בהם ולהכנתם (Opioid receptor ligands and methods of using and making same) | ⤷ Try a Trial |
European Patent Office | 3872076 | LIGANDS DE RÉCEPTEURS OPÏOIDES, ET LEURS PROCÉDÉS D'UTILISATION ET DE PRODUCTION (OPIOID RECEPTOR LIGANDS AND METHODS OF USING AND MAKING SAME) | ⤷ Try a Trial |
Serbia | 56111 | LIGANDI OPIOIDNIH RECEPTORA I POSTUPCI NJIHOVE UPOTREBE I PRIPREME (OPIOID RECEPTOR LIGANDS AND METHODS OF USING AND MAKING SAME) | ⤷ Try a Trial |
Hong Kong | 1250984 | 阿片樣物質受體配體以及使用和製備其的方法 (OPIOID RECEPTOR LIGANDS AND METHODS OF USING AND MAKING SAME) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |